EFICACIA DE LA DEXAMETASONA EN SINDROME HELLP
Después de la administración de dexametasona (vía EV en dosis de 10 mg. cada 12 horas) a una paciente de 26 semanas de gestación, hipertensa crónica con preeclampsia sobreagregada y síndrome Hellp, se aprecia estabilización y disminución de enzimas hepáticas (principalmente SGOT/AST), LDH y...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Permanyer,
2003-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_704c43cd77b0417d8c6f8a62d6ed27c7 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Ramón Almuna V. |e author |
| 700 | 1 | 0 | |a Luisa Valdés F. |e author |
| 700 | 1 | 0 | |a Carlos Ramírez F. |e author |
| 700 | 1 | 0 | |a Verónica Barrera C. |e author |
| 700 | 1 | 0 | |a Federico Bakal I. |e author |
| 700 | 1 | 0 | |a Irene Montoya C. |e author |
| 245 | 0 | 0 | |a EFICACIA DE LA DEXAMETASONA EN SINDROME HELLP |
| 260 | |b Permanyer, |c 2003-01-01T00:00:00Z. | ||
| 500 | |a 0048-766X | ||
| 500 | |a 0717-7526 | ||
| 520 | |a Después de la administración de dexametasona (vía EV en dosis de 10 mg. cada 12 horas) a una paciente de 26 semanas de gestación, hipertensa crónica con preeclampsia sobreagregada y síndrome Hellp, se aprecia estabilización y disminución de enzimas hepáticas (principalmente SGOT/AST), LDH y aumento de recuento de plaquetas, no observándose variaciones en los niveles de ácido úrico, creatinuria, proteinuria y calciuria<br>After the administration of i.v. dexamethasone (10 mg every 12 hours) to a pregnant woman at 26 weeks, with chronic hypertension and superimposed pre-eclampsia and Hellp syndrome, we observed the stabilization and decrease of liver enzymes level (specially SGOT/AST) LDH and increase in platelets count with no changes in uric acid blood level and creatinin, protein and calcium urine levels | ||
| 546 | |a EN | ||
| 546 | |a ES | ||
| 690 | |a Síndrome de Hellp | ||
| 690 | |a dexametasona | ||
| 690 | |a Hellp syndrome | ||
| 690 | |a dexamethasone | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Revista Chilena de Obstetricia y Ginecología, Vol 68, Iss 6, Pp 508-512 (2003) | |
| 787 | 0 | |n http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262003000600010 | |
| 787 | 0 | |n https://doaj.org/toc/0048-766X | |
| 787 | 0 | |n https://doaj.org/toc/0717-7526 | |
| 856 | 4 | 1 | |u https://doaj.org/article/704c43cd77b0417d8c6f8a62d6ed27c7 |z Connect to this object online. |